Delivery Order SPE2DB24D2012-SPE2DB25FBWMN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $2,977 to AmerisourceBergen Drug Corp for Ebygloss 250 mg/2 mL pen medication on August 4, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is structured as a child contract under a larger vehicle, leveraging the company's existing federal procurement relationship to supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,747.38 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ebglyss 250 mg/2 ml pen (2 ml). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this award...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ebyglss 250 mg/2 mL pen (2 mL) with a ceiling value of $4,121.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,700.74 to AmerisourceBergen Drug Corp for EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product for federal medical supply needs. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.93 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ebyglss 250 mg/2 ml pen (2 ml). This firm fixed-price, competitively awarded contract involves a non-set-aside procurement and is scheduled for completion by July 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,860.57 to AmerisourceBergen Drug Corp for Ebglyss 250 mg/2 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $17,894.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is set to be completed by July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,129.52 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWMNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,885.03 to AmerisourceBergen Drug Corp for Ebylass 250 mg/2 ml pen (2 ml), a pharmaceutical product for federal medical procurement. The contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its Corporate Office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates its capability to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The firm's consistent receipt of competitively awarded delivery orders with firm fixed pricing, ranging from modest to substantial values, reflects its established position as a qualified supplier for federal medical procurement needs supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 7/23/25 |